DGCAMar 15
5 Stocks To Buy For Long Term: Goldman Sachs picks stocks for 2026 with up to 106% upside; LG Electronics, Eicher Motors, Info Edge on list
- Written by Ankit Kumar
Published: Zee Business| Updated: Zee Business
5 Stocks To Buy For Long Term: Goldman Sachs has identified Eicher Motors, LG Electronics, Info Edge India, Hindustan Unilever (HUL) and Cohance Lifesciences as its top long-term stock picks for 2026 across automobiles, consumer durables, internet services, FMCG and pharmaceuticals. The brokerage has maintained Buy ratings on all five stocks, citing strong earnings visibility, sector tailwinds and improving business momentum. Based on current market prices and target prices shared by Goldman Sachs, the potential upside across these stocks goes up to around 106 per cent, making them attractive options for long-term investors seeking steady growth.
Representational image: Unsplash
1/6
Eicher Motors Share Price Target | Upside 17%
1/6Eicher Motors is rated Buy, with the stock trading at Rs 7,897 and a revised target price of Rs 9,200, implying an upside of around 16.5 per cent. Goldman Sachs raised its target from Rs 8,600, reflecting confidence in the company’s long-term premium two-wheeler demand outlook.
2/6
LG Electronics Share Price Target | Upside 13%
2/6LG Electronics carries a Buy rating, trading at Rs 1,547.90 with a target price of Rs 1,750, indicating an upside of about 13.1 per cent. Goldman Sachs expects the market leader to benefit from India’s evolving demographics, premiumisation and innovation-led product mix, while B2B and AMC businesses provide additional growth levers.
3/6
Info Edge India Share Price Target | Upside 40%
3/6Info Edge India is rated Buy, with the stock trading at Rs 1,094.40 and a target price of Rs 1,530, translating into an upside of around 39.8 per cent. Goldman Sachs maintained its positive view despite cutting the target from Rs 1,700.
4/6
Hindustan Unilever Share Price Target | Upside 21%
4/6Hindustan Unilever is rated Buy, with the stock trading at Rs 2,279.30 and a target price of Rs 2,750, implying an upside of around 20.7 per cent. Goldman Sachs expects gradual recovery ahead, supported by strategic initiatives, stronger home care growth and organisational changes aimed at faster innovation.
5/6
Cohance Lifesciences Share Price Target | Upside 106%
5/6Cohance Lifesciences carries a Buy rating, trading at Rs 315.10 with a target price of Rs 650, suggesting an upside of about 106.3 per cent. Goldman Sachs remains constructive on the stock’s long-term growth potential despite trimming the target from Rs 750.
6/6
Disclaimer
6/6The views/suggestions/recommendations expressed in this article are solely those of investment experts. The platform does not advise investors to buy or sell stocks. Please consult your financial adviser before making investment decisions.
- 1
- 2
- 3
- 4
- 5
- 6